The combination is designed to produce additive weight loss beyond what either molecule achieves independently
59 In MASLD patients with inadequate glycemic control on metformin, sitagliptin (a DPP-4 inhibitor) and liraglutide 1.8 mg daily showed no significant differences in improving LFC assessed by MRI-PDFF, visceral adipose tissue, and weight reduction
Pharmacological characterization of human incretin receptor missense variants
The competition between pharmaceutical companies to capture a share of the weight loss market has led to significant investment in research and development, as well as partnerships with healthcare providers and insurers to promote the safe and effective use of these medications
Front Endocrinol (Lausanne) (2019) 10:389
For example, earlier research in rats demonstrated that menadione, a compound that induces reactive oxygen species (ROS), causes oxidative DNA damage and leads to apoptosis in neurons
